EURO PCR 2017 – AKI Matrix Late Breaking – Sub Study MATRIX

EURO PCR 2017 – AKI Matrix Late Breaking – Sub Study MATRIX

During the EuroPCR 2017, have been presented the Study AKI Matrix – Association between Radial or Femoral Access and Acute Kidney Injury in Patients with Acute Coronary Syndromes Undergoing Invasive Management.
The Objective of the study is to assess the incidence of AKI in patients with acute coronary syndrome (ACS) enrolled in the MATRIX-Access Trial.

3 IMG_3810

Conclusion

– The results of this pre-specified substudy of the MATRIX Program show how a TR access results in fewer AKIs in ACS patients (both STE and not).
– Our findings are consistent in several subgroups.

Here’s the presentation of the meeting

3 AKI Matrix LBCT final
Twelve-month results of an unrestricted use  of bioresorbable vascular scaffolds in a real  world coronary artery disease population:  primary outcome of the prospective RAI  registry

Twelve-month results of an unrestricted use of bioresorbable vascular scaffolds in a real world coronary artery disease population: primary outcome of the prospective RAI registry

During the EuroPCR 2017, I presented the results of the first year of Follow-Up for the RAI Registry, a spontaneous, multicenter, prospective data collection on consecutive patients undergoing BVS implantation in Italy.
The Objective of the Registry is to evaluate the long-term safety and efficacy of Absorb BVS within an unrestricted cohort of patients undergoing PCI. There have been enrolled 1505 Patients in 25 Italian Centers.

2 IMG_3789

Conclusion

•The RAI registry represents a real world, contemporary
BVS population, with very few exclusion criteria.
• The population enrolled is extremely well treated
(predilatation, postdilatation).
• Current-era BVS use, according to specific and
standardized techniques of implantation, show good
clinical outcome in an unrestricted patient population at
mid-term follow up.

Here’s the presentation of the meeting

2 RAI 12m
Investigator Meeting EASTBOURNE Registry @Euro PCR 2017

Investigator Meeting EASTBOURNE Registry @Euro PCR 2017

1 IMG_3821  During the EuroPCR 2017, I met 45 PI of the EASTBOURNE Registry to talk about the end point and the trend of      the Study. There were PI from all around the world (Spain, China, Italy, Japan, England, India, etc.).

The EASTBOURNE Registry, thE All-comers Sirolimus-coaTed BallOon eURopeaN rEgistry, has been created to observe and evaluate the performance of a Sirolimus-
eluting Drug-Coated Balloon (SCB) for the treatment of any type of coronary lesions, including native vessel disease and in-stent restenosis.

The Registry has the following characteristics:
•Prospective, multicenter, spontaneous clinical registry
•Consecutive enrollment
•real world, all comers patients

Here’s the presentation of the meeting

1 EASTBOURNE Investigator Meeting